OpenURL Connection Search

Select item for more details and to access through your institution.

Effects of insulin-induced hypoglycaemia on energy intake and food choice at a subsequent test meal.
Published in:
Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 5, p. 405, doi. 10.1002/dmrr.471
By:
- Dewan, Shivani;
- Gillett, Angela;
- Mugarza, Julie A.;
- Dovey, Terence M.;
- Halford, Jason C. G.;
- Wilding, John P. H.
Publication type:
Article
The double burden of malnutrition in individuals: Identifying key challenges and re‐thinking research focus.
Published in:
Nutrition Bulletin, 2024, v. 49, n. 2, p. 132, doi. 10.1111/nbu.12670
By:
- Kiosia, Agklinta;
- Dagbasi, Aygul;
- Berkley, James A.;
- Wilding, John P. H.;
- Prendergast, Andrew J.;
- Li, Jia V.;
- Swann, Jon;
- Mathers, John C.;
- Kerac, Marko;
- Morrison, Douglas;
- Drake, Lesley;
- Briend, Andre;
- Maitland, Kathryn;
- Frost, Gary
Publication type:
Article
Short-Term Physical Inactivity Induces Endothelial Dysfunction.
Published in:
Frontiers in Physiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphys.2021.659834
By:
- Bowden Davies, Kelly A.;
- Norman, Juliette A.;
- Thompson, Andrew;
- Mitchell, Katie L.;
- Harrold, Joanne A.;
- Halford, Jason C. G.;
- Wilding, John P. H.;
- Kemp, Graham J.;
- Cuthbertson, Daniel J.;
- Sprung, Victoria S.
Publication type:
Article
Obstructive sleep apnoea in patients with type 2 diabetes: aetiology and implications for clinical care.
Published in:
Diabetes, Obesity & Metabolism, 2009, v. 11, n. 8, p. 733, doi. 10.1111/j.1463-1326.2009.01045.x
By:
- Idris, Iskandar;
- Hall, Andrew P.;
- O'Reilly, John;
- Barnett, Anthony;
- Allen, Martin;
- Andrews, Robert;
- Grunstein, Phillipe;
- Lewis, Keir;
- Goenka, Niru;
- Wilding, John P.
Publication type:
Article
The dual PPARa/?agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.
Published in:
2005
By:
- Pickavance, Lucy C;
- Brand, Christian L;
- Wassermann, Karsten;
- Wilding, John P H
Publication type:
Abstract
Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
Published in:
Diabetologia, 2024, v. 67, n. 7, p. 1271, doi. 10.1007/s00125-024-06132-5
By:
- Eleftheriadou, Aikaterini;
- Riley, David;
- Zhao, Sizheng S.;
- Austin, Philip;
- Hernández, Gema;
- Lip, Gregory Y. H.;
- Jackson, Timothy L.;
- Wilding, John P. H.;
- Alam, Uazman
Publication type:
Article
The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus.
Published in:
Diabetologia, 2021, v. 64, n. 6, p. 1226, doi. 10.1007/s00125-021-05399-2
By:
- O'Donoghue, Michelle L.;
- Kato, Eri T.;
- Mosenzon, Ofri;
- Murphy, Sabina A.;
- Cahn, Avivit;
- Herrera, Marisol;
- Tankova, Tsvetalina;
- Šmahelová, Alena;
- Merlini, Piera;
- Gause-Nilsson, Ingrid;
- Langkilde, Anna Maria;
- McGuire, Darren K.;
- Wilding, John P. H.;
- Leiter, Larry A.;
- Bhatt, Deepak L.;
- Raz, Itamar;
- Sabatine, Marc S.;
- Wiviott, Stephen D.
Publication type:
Article
The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review.
Published in:
Diabetologia, 2021, v. 64, n. 2, p. 288, doi. 10.1007/s00125-020-05316-z
By:
- Eleftheriadou, Aikaterini;
- Williams, Scott;
- Nevitt, Sarah;
- Brown, Emily;
- Roylance, Rebecca;
- Wilding, John P. H.;
- Cuthbertson, Daniel J.;
- Alam, Uazman
Publication type:
Article
Short-term decreased physical activity with increased sedentary behaviour causes metabolic derangements and altered body composition: effects in individuals with and without a first-degree relative with type 2 diabetes.
Published in:
Diabetologia, 2018, v. 61, n. 6, p. 1282, doi. 10.1007/s00125-018-4603-5
By:
- Bowden Davies, Kelly A.;
- Sprung, Victoria S.;
- Norman, Juliette A.;
- Thompson, Andrew;
- Mitchell, Katie L.;
- Halford, Jason C. G.;
- Harrold, Jo A.;
- Wilding, John P. H.;
- Kemp, Graham J.;
- Cuthbertson, Daniel J.
Publication type:
Article
Medication use for the treatment of diabetes in obese individuals.
Published in:
Diabetologia, 2018, v. 61, n. 2, p. 265, doi. 10.1007/s00125-017-4288-1
By:
- Wilding, John P. H.
Publication type:
Article
Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.
Published in:
2017
By:
- Budoff, Matthew J.;
- Wilding, John P. H.
Publication type:
journal article
No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled, cross‐over trial (ENERGIZE)
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3621, doi. 10.1111/dom.15257
By:
- Rajeev, Surya Panicker;
- Roberts, Carl Alexander;
- Brown, Emily;
- Sprung, Victoria S.;
- Harrold, Jo A.;
- Halford, Jason C. G.;
- Stancak, Andrej;
- Boyland, Emma J.;
- Kemp, Graham J.;
- Perry, Julie;
- Howarth, Elaine;
- Jackson, Richard;
- Wiemken, Andrew;
- Schwab, Richard;
- Cuthbertson, Daniel J.;
- Wilding, John P. H.
Publication type:
Article
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1553, doi. 10.1111/dom.14725
By:
- Wilding, John P. H.;
- Batterham, Rachel L.;
- Davies, Melanie;
- Van Gaal, Luc F.;
- Kandler, Kristian;
- Konakli, Katerina;
- Lingvay, Ildiko;
- McGowan, Barbara M.;
- Oral, Tugce Kalayci;
- Rosenstock, Julio;
- Wadden, Thomas A.;
- Wharton, Sean;
- Yokote, Koutaro;
- Kushner, Robert F.
Publication type:
Article
The effects of empagliflozin, dietary energy restriction, or both on appetite‐regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double‐blind, placebo‐controlled trial.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1509, doi. 10.1111/dom.14721
By:
- Sargeant, Jack A.;
- King, James A.;
- Yates, Thomas;
- Redman, Emma L.;
- Bodicoat, Danielle H.;
- Chatterjee, Sudesna;
- Edwardson, Charlotte L.;
- Gray, Laura J.;
- Poulin, Benoit;
- Waheed, Ghazala;
- Waller, Helen L.;
- Webb, David R.;
- Willis, Scott A.;
- Wilding, John P. H.;
- Khunti, Kamlesh;
- Stensel, David J.;
- Davies, Melanie J.
Publication type:
Article
Long‐term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104‐week extension to a 52‐week randomized, phase 3 study and liver fat MRI substudy.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 61, doi. 10.1111/dom.14548
By:
- Frías, Juan P.;
- Maaske, Jill;
- Suchower, Lisa;
- Johansson, Lars;
- Hockings, Paul D.;
- Iqbal, Nayyar;
- Wilding, John P. H.
Publication type:
Article
Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58.
Published in:
Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 29, doi. 10.1111/dom.14179
By:
- Cahn, Avivit;
- Wiviott, Stephen D.;
- Mosenzon, Ofri;
- Murphy, Sabina A.;
- Goodrich, Erica L.;
- Yanuv, Ilan;
- Rozenberg, Aliza;
- Wilding, John P. H.;
- Leiter, Lawrence A.;
- Bhatt, Deepak L.;
- McGuire, Darren K.;
- Litwak, Leon;
- Kooy, Adriaan;
- Gause‐Nilsson, Ingrid A. M.;
- Fredriksson, Martin;
- Langkilde, Anna Maria;
- Sabatine, Marc S.;
- Raz, Itamar
Publication type:
Article
Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE‐TIMI 58 study.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1357, doi. 10.1111/dom.14041
By:
- Cahn, Avivit;
- Raz, Itamar;
- Bonaca, Marc;
- Mosenzon, Ofri;
- Murphy, Sabina A.;
- Yanuv, Ilan;
- Rozenberg, Aliza;
- Wilding, John P. H.;
- Bhatt, Deepak L.;
- McGuire, Darren K.;
- Gause‐Nilsson, Ingrid A. M.;
- Fredriksson, Martin;
- Johansson, Peter A.;
- Jermendy, Gyorgy;
- Hadjadj, Samy;
- Langkilde, Anna Maria;
- Sabatine, Marc S.;
- Wiviott, Stephen D.;
- Leiter, Lawrence A.
Publication type:
Article
Cover Image, Volume 22, Issue 7.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1, doi. 10.1111/dom.14113
By:
- Johansson, Lars;
- Hockings, Paul D.;
- Johnsson, Eva;
- Dronamraju, Nalina;
- Maaske, Jill;
- Garcia‐Sanchez, Ricardo;
- Wilding, John P. H.
Publication type:
Article
Cardiovascular and renal benefits of dapagliflozin in patients with short and long‐standing type 2 diabetes: Analysis from the DECLARE‐TIMI 58 trial.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1122, doi. 10.1111/dom.14011
By:
- Bajaj, Harpreet S.;
- Raz, Itamar;
- Mosenzon, Ofri;
- Murphy, Sabina A.;
- Rozenberg, Aliza;
- Yanuv, Ilan;
- Bhatt, Deepak L.;
- Leiter, Lawrence A.;
- McGuire, Darren K.;
- Wilding, John P. H.;
- Gause‐Nilsson, Ingrid A. M.;
- Sabatine, Marc S.;
- Wiviott, Stephen D.;
- Cahn, Avivit
Publication type:
Article
Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1094, doi. 10.1111/dom.14004
By:
- Johansson, Lars;
- Hockings, Paul D.;
- Johnsson, Eva;
- Dronamraju, Nalina;
- Maaske, Jill;
- Garcia‐Sanchez, Ricardo;
- Wilding, John P. H.
Publication type:
Article
A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium‐glucose co‐transporter‐2 inhibitors.
Published in:
Diabetes, Obesity & Metabolism, 2019, v. 21, p. 9, doi. 10.1111/dom.13650
By:
- Brown, Emily;
- Rajeev, Surya P.;
- Cuthbertson, Daniel J.;
- Wilding, John P. H.
Publication type:
Article
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials.
Published in:
Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2210, doi. 10.1111/dom.13353
By:
- Ahrén, Bo;
- Atkin, Stephen L.;
- Charpentier, Guillaume;
- Warren, Mark L.;
- Wilding, John P. H.;
- Birch, Sune;
- Holst, Anders Gaarsdal;
- Leiter, Lawrence A.
Publication type:
Article
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study.
Published in:
Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1983, doi. 10.1111/dom.13299
By:
- Kosiborod, Mikhail;
- Birkeland, Kåre I.;
- Cavender, Matthew A.;
- Fu, Alex Z.;
- Wilding, John P.;
- Khunti, Kamlesh;
- Holl, Reinhard W.;
- Norhammar, Anna;
- Jørgensen, Marit E.;
- Wittbrodt, Eric T.;
- Thuresson, Marcus;
- Bodegård, Johan;
- Hammar, Niklas;
- Fenici, Peter;
- the CVD‐REAL Investigators and Study Group
Publication type:
Article
DECLARE‐TIMI 58: Participants’ baseline characteristics.
Published in:
Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1102, doi. 10.1111/dom.13217
By:
- Raz, Itamar;
- Mosenzon, Ofri;
- Cahn, Avivit;
- Bonaca, Marc P.;
- Silverman, Michael G.;
- Bhatt, Deepak L.;
- Sabatine, Marc S.;
- Wiviott, Stephen D.;
- Kato, Eri T.;
- Leiter, Lawrence A.;
- McGuire, Darren K.;
- Wilding, John P. H.;
- Gause‐Nilsson, Ingrid A. M.;
- Langkilde, Anna M.;
- Johansson, Peter A.
Publication type:
Article
Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.
Published in:
Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1529, doi. 10.1111/dom.12963
By:
- O'Neil, Patrick M.;
- Aroda, Vanita R.;
- Astrup, Arne;
- Kushner, Robert;
- Lau, David C. W.;
- Wadden, Thomas A.;
- Brett, Jason;
- Cancino, Ana‐Paula;
- Wilding, John P. H.
Publication type:
Article
Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors.
Published in:
Drugs, 2021, v. 81, n. 11, p. 1243, doi. 10.1007/s40265-021-01538-6
By:
- Evans, Marc;
- Morgan, Angharad R.;
- Yousef, Zaheer;
- Ellis, Gethin;
- Dashora, Umesh;
- Patel, Dipesh C.;
- Brown, Pam;
- Hanif, Wasim;
- Townend, Johnathan N.;
- Kanumilli, Naresh;
- Moore, Jim;
- Wilding, John P. H.;
- Bain, Stephen C.
Publication type:
Article
1,25-dihydroxyvitamin D3 Protects against Macrophage-Induced Activation of NFκB and MAPK Signalling and Chemokine Release in Human Adipocytes.
Published in:
PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061707
By:
- Ding, Cherlyn;
- Wilding, John P. H.;
- Bing, Chen
Publication type:
Article
Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial.
Published in:
European Heart Journal, 2022, v. 43, n. 31, p. 2958, doi. 10.1093/eurheartj/ehab530
By:
- Oyama, Kazuma;
- Raz, Itamar;
- Cahn, Avivit;
- Kuder, Julia;
- Murphy, Sabina A;
- Bhatt, Deepak L;
- Leiter, Lawrence A;
- McGuire, Darren K;
- Wilding, John P H;
- Park, Kyong Soo;
- Goudev, Assen;
- Diaz, Rafael;
- Špinar, Jindřich;
- Gause-Nilsson, Ingrid A M;
- Mosenzon, Ofri;
- Sabatine, Marc S;
- Wiviott, Stephen D
Publication type:
Article
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes.
Published in:
Current Atherosclerosis Reports, 2024, v. 26, n. 1, p. 1, doi. 10.1007/s11883-023-01181-4
By:
- Zhu, Jingjing;
- Wilding, John P. H.
Publication type:
Article
Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 1, p. 34, doi. 10.1210/jc.2009-0473
By:
- Nair, Sunil;
- Wilding, John P. H.
Publication type:
Article
Is There a Role for Ghrelin and Peptide-YY in the Pathogenesis of Obesity in Adults with Acquired Structural Hypothalamic Damage?
Published in:
Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 9, p. 5025, doi. 10.1210/jc.2004-1874
By:
- Daousi, Christina;
- MacFarlane, Ian A.;
- English, Patrick J.;
- Wilding, John P. H.;
- Patterson, Michael;
- Dovey, Terence M.;
- Halford, Jason C. G.;
- Ghatei, Mohammad A.;
- Pinkney, Jonathan H.
Publication type:
Article
Metabolic syndrome is associated with reduced flow mediated dilation independent of obesity status.
Published in:
European Journal of Endocrinology, 2020, v. 183, n. 2, p. 211, doi. 10.1530/EJE-20-0098
By:
- Sprung, Victoria S.;
- Davies, Kelly A. Bowden;
- Norman, Juliette A.;
- Thompson, Andrew;
- Mitchell, Katie L.;
- Wilding, John P. H.;
- Kemp, Graham J.;
- Cuthbertson, Daniel J.
Publication type:
Article
Endocrine testing in obesity.
Published in:
European Journal of Endocrinology, 2020, v. 182, n. 4, p. C13, doi. 10.1530/EJE-20-0099
By:
- Wilding, John P. H.
Publication type:
Article
Hypothalamic obesity: prevalence, associations and longitudinal trends in weight in a specialist adult neuroendocrine clinic.
Published in:
European Journal of Endocrinology, 2013, v. 168, n. 4, p. 501, doi. 10.1530/EJE-12-0792
By:
- Steele, Caroline A.;
- Cuthbertson, Daniel J.;
- MacFarlane, Ian A.;
- Javadpour, Mohsen;
- Das, Kumar S. V.;
- Gilkes, Catherine;
- Wilding, John P.;
- Daousi, Christina
Publication type:
Article
Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscle.
Published in:
Clinical Science, 2014, v. 127, n. 12, p. 655, doi. 10.1042/CS20130404
By:
- CUTHBERTSON, Daniel J.;
- IRWIN, Andrew;
- SPRUNG, Victoria S.;
- JONES, Helen;
- PUGH, Christopher J. A.;
- DAOUSI, Christina;
- ADAMS, Valerie L.;
- BIMSON, William E.;
- SHOJAEE-MORADIE, Fariba;
- RICHARDSON, Paul;
- UMPLEBY, A. Margot;
- WILDING, John P.;
- KEM, Graham J.
Publication type:
Article
Reduced NPY Induced Feeding in Diabetic but not Steroid-Treated Rats: Lack of Evidence for Changes in Receptor Number or Affinity.
Published in:
Journal of Neuroendocrinology, 1996, v. 8, n. 4, p. 283, doi. 10.1046/j.1365-2826.1996.04565.x
By:
- Morgan, David G. A.;
- Lambert, Philip D.;
- Smith, David M.;
- Wilding, John P. H.;
- Bloom, Stephen R.
Publication type:
Article
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation.
Published in:
European Journal of Preventive Cardiology, 2022, v. 29, n. 17, p. 2218, doi. 10.1093/eurjpc/zwac187
By:
- Lopez-Jimenez, Francisco;
- Almahmeed, Wael;
- Bays, Harold;
- Cuevas, Ada;
- Angelantonio, Emanuele Di;
- Roux, Carel W le;
- Sattar, Naveed;
- Sun, Marie Chan;
- Wittert, Gary;
- Pinto, Fausto J;
- Wilding, John P H
Publication type:
Article
Urinary proteomics in obstructive sleep apnoea and obesity.
Published in:
European Journal of Clinical Investigation, 2014, v. 44, n. 11, p. 1104, doi. 10.1111/eci.12346
By:
- Seetho, Ian W.;
- Siwy, Justyna;
- Albalat, Amaya;
- Mullen, William;
- Mischak, Harald;
- Parker, Robert J.;
- Craig, Sonya;
- Duffy, Nick;
- Hardy, Kevin J.;
- Burniston, Jatin G.;
- Wilding, John P. H.
Publication type:
Article
Differential vascular dysfunction in response to diets of differing macronutrient composition: a phenomenonological study.
Published in:
Nutrition & Metabolism, 2007, v. 4, p. 15, doi. 10.1186/1743-7075-4-15
By:
- Fatani, Sameer;
- Pickavance, Lucy C.;
- Sadler, Claire J.;
- Harrold, Joanne A.;
- Cassidy, Roslyn;
- Wilding, John P. H.;
- Naderali, Ebrahim K.
Publication type:
Article
Corneal Confocal Microscopy Predicts Cardiovascular and Cerebrovascular Events and Demonstrates Greater Peripheral Neuropathy in Patients with Type 1 Diabetes and Foot Ulcers.
Published in:
Diagnostics (2075-4418), 2023, v. 13, n. 17, p. 2793, doi. 10.3390/diagnostics13172793
By:
- Lim, Jonathan Z. M.;
- Burgess, Jamie;
- Ooi, Cheong;
- Ferdousi, Maryam;
- Azmi, Shazli;
- Kalteniece, Alise;
- Anson, Matthew;
- Cuthbertson, Daniel J.;
- Petropoulos, Ioannis N.;
- Malik, Rayaz A.;
- Wilding, John P. H.;
- Alam, Uazman
Publication type:
Article
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review.
Published in:
Diabetes Therapy, 2024, v. 15, n. 5, p. 1099, doi. 10.1007/s13300-024-01550-5
By:
- Seidu, Samuel;
- Alabraba, Vicki;
- Davies, Sarah;
- Newland-Jones, Philip;
- Fernando, Kevin;
- Bain, Stephen C.;
- Diggle, Jane;
- Evans, Marc;
- James, June;
- Kanumilli, Naresh;
- Milne, Nicola;
- Viljoen, Adie;
- Wheeler, David C.;
- Wilding, John P. H.
Publication type:
Article
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review.
Published in:
Diabetes Therapy, 2022, v. 13, n. 5, p. 847, doi. 10.1007/s13300-022-01228-w
By:
- Wilding, John P. H.;
- Evans, Marc;
- Fernando, Kevin;
- Gorriz, Jose Luis;
- Cebrian, Ana;
- Diggle, Jane;
- Hicks, Debbie;
- James, June;
- Newland-Jones, Philip;
- Ali, Amar;
- Bain, Stephen;
- Da Porto, Andrea;
- Patel, Dipesh;
- Viljoen, Adie;
- Wheeler, David C.;
- Del Prato, Stefano
Publication type:
Article
Correction to: Cardiac Autonomic Neuropathy in Obesity, Metabolic Syndrome and Prediabetes: A Narrative Review.
Published in:
2019
By:
- Williams, Scott M.;
- Eleftheriadou, Aikaterini;
- Alam, Uazman;
- Cuthbertson, Daniel J.;
- Wilding, John P. H.
Publication type:
Correction Notice
Safety of Ipragliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials.
Published in:
Diabetes Therapy, 2019, v. 10, n. 6, p. 2201, doi. 10.1007/s13300-019-00699-8
By:
- Kashiwagi, Atsunori;
- Shestakova, Marina V.;
- Ito, Yuichiro;
- Noguchi, Masahiro;
- Wilpshaar, Wim;
- Yoshida, Satoshi;
- Wilding, John P. H.
Publication type:
Article
Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review.
Published in:
Diabetes Therapy, 2019, v. 10, n. 6, p. 1995, doi. 10.1007/s13300-019-00693-0
By:
- Williams, Scott M.;
- Eleftheriadou, Aikaterini;
- Alam, Uazman;
- Cuthbertson, Daniel J.;
- Wilding, John P. H.
Publication type:
Article
Patients’ Perspectives of Oral and Injectable Type 2 Diabetes Medicines, Their Body Weight and Medicine-Taking Behavior in the UK: A Systematic Review and Meta-Ethnography.
Published in:
Diabetes Therapy, 2018, v. 9, n. 5, p. 1791, doi. 10.1007/s13300-018-0490-5
By:
- Psarou, Aikaterini;
- Wilding, John P. H.;
- Cooper, Helen
Publication type:
Article
1α,25(OH)2D3 attenuates IL-6 and IL-1β-mediated inflammatory responses in macrophage conditioned medium-stimulated human white preadipocytes by modulating p44/42 MAPK and NF-κB signaling pathways.
Published in:
Diabetology & Metabolic Syndrome, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13098-019-0405-2
By:
- Zhu, Jingjing;
- Bing, Chen;
- Wilding, John P. H.
Publication type:
Article
Serum urate and obstructive sleep apnoea in severe obesity.
Published in:
Chronic Respiratory Disease, 2015, v. 12, n. 3, p. 238, doi. 10.1177/1479972315586197
By:
- Seetho, Ian W.;
- Parker, Robert J.;
- Craig, Sonya;
- Duffy, Nick;
- Hardy, Kevin J.;
- Wilding, John P. H.;
- Goodson, Nicola J.
Publication type:
Article
Chronic treatment with the thiazolidinedione, MCC-555, is associated with reductions in nitric oxide synthase activity and β-cell apoptosis in the pancreas of the Zucker Diabetic Fatty rat.
Published in:
International Journal of Experimental Pathology, 2003, v. 84, n. 2, p. 83, doi. 10.1046/j.1365-2613.2003.00337.x
By:
- Pickavance, Lucy C.;
- Widdowson, Peter S.;
- Foster, John R.;
- Williams, Gareth;
- Wilding, John P. H.
Publication type:
Article
Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.
Published in:
2012
By:
- Wilding JP;
- Woo V;
- Soler NG;
- Pahor A;
- Sugg J;
- Rohwedder K;
- Parikh S;
- Dapagliflozin 006 Study Group;
- Wilding, John P H;
- Woo, Vincent;
- Soler, Norman G;
- Pahor, Andrea;
- Sugg, Jennifer;
- Rohwedder, Katja;
- Parikh, Shamik
Publication type:
journal article

Found: 66